Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A02527 | 34340957 | Endocrinol Diabetes Nutr (Engl Ed) | Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity. | 2021 | Details |
| A02530 | 34339944 | Phytomedicine | Network pharmacology-based identification of significant pathway for protection of Yinhuang granule in a mice model of metabolic-associated fatty liver disease. | 2021 | Details |
| A02534 | 34337887 | J Cachexia Sarcopenia Muscle | Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease. | 2021 | Details |
| A02539 | 34335686 | Front Genet | The Co-occurrence of Chronic Hepatitis B and Fibrosis Is Associated With a Decrease in Hepatic Global DNA Methylation Levels in Patients With Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A02542 | 34334708 | Eur J Gastroenterol Hepatol | Predictive value of cytokeratin-18 fragment levels for diagnosing steatohepatitis in patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A02543 | 34333790 | Hepatology | A Machine Learning Approach to Liver Histological Evaluation Predicts Clinically Significant Portal Hypertension in NASH Cirrhosis. | 2021 | Details |
| A02550 | 34331779 | Hepatology | Hepatic Mitochondrial SAB Deletion or Knockdown Alleviates Diet-Induced Metabolic Syndrome, Steatohepatitis, and Hepatic Fibrosis. | 2021 | Details |
| A02551 | 34331020 | Pediatr Res | Angiopoietin-2 levels correlates with disease activity in children with nonalcoholic fatty liver disease. | 2021 | Details |
| A02553 | 34330512 | Clin Nutr ESPEN | Triglyceride glucose (TyG) index and the progression of liver fibrosis: A cross-sectional study. | 2021 | Details |
| A02557 | 34328687 | Liver Int | Zonation in NASH - A key paradigm for understanding pathophysiology and clinical outcomes. | 2021 | Details |
| A02562 | 34328087 | Biomed Pharmacother | Supplementation of cumin seed powder prevents oxidative stress, hyperlipidemia and non-alcoholic fatty liver in high fat diet fed rats. | 2021 | Details |
| A02570 | 34326695 | Int J Biol Sci | Aberrant FGFR4 signaling worsens nonalcoholic steatohepatitis in FGF21KO mice. | 2021 | Details |
| A02571 | 34326608 | World J Gastroenterol | Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion. | 2021 | Details |
| A02576 | 34325952 | J Formos Med Assoc | The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool? | 2021 | Details |
| A02583 | 34322898 | Hepatology | Guanine Nucleotide-Binding Protein G(i) Subunit Alpha 2 Exacerbates NASH Progression by Regulating Peroxiredoxin 1-Related Inflammation and Lipophagy. | 2021 | Details |
| A02586 | 34321990 | Prz Menopauzalny | Bariatric surgery: blessing or sometimes curse for the liver? | 2021 | Details |
| A02587 | 34321850 | World J Gastroenterol | PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A02594 | 34321089 | Stem Cell Res Ther | Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease/non-alcoholic steatohepatitis using amniotic epithelial cells. | 2021 | Details |
| A02597 | 34320238 | Hepatology | SIMPLE Is an Endosomal Regulator That Protects Against NAFLD by Targeting the Lysosomal Degradation of EGFR. | 2021 | Details |
| A02599 | 34319647 | Mol Nutr Food Res | The Association Between Coffee Consumption and Nonalcoholic Fatty Liver Disease in the South Korean General Population. | 2021 | Details |
| A02601 | 34314787 | Adv Drug Deliv Rev | Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis. | 2021 | Details |
| A02606 | 34311531 | Biomed Pharmacother | FTZ attenuates liver steatosis and fibrosis in the minipigs with type 2 diabetes by regulating the AMPK signaling pathway. | 2021 | Details |
| A02607 | 34311134 | Clin Res Hepatol Gastroenterol | Non-invasive assessment of fibrosis and steatosis in pediatric non-alcoholic fatty liver disease. | 2021 | Details |
| A02610 | 34310978 | Gastroenterology | TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial. | 2021 | Details |
| A02619 | 34307562 | World J Clin Cases | Impact of continuous positive airway pressure therapy for nonalcoholic fatty liver disease in patients with obstructive sleep apnea. | 2021 | Details |
| A02620 | 34307250 | Front Pediatr | Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and Adolescents. | 2021 | Details |
| A02627 | 34304139 | Biomaterials | A fully defined matrix to support a pluripotent stem cell derived multi-cell-liver steatohepatitis and fibrosis model. | 2021 | Details |
| A02628 | 34303881 | Cell Mol Gastroenterol Hepatol | White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice. | 2021 | Details |
| A02629 | 34303827 | Clin Res Hepatol Gastroenterol | Metabolically healthy and unhealthy obesity and the progression of liver fibrosis: A cross-sectional study. | 2021 | Details |
| A02636 | 34300193 | J Clin Med | Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis. | 2021 | Details |
| A02639 | 34299321 | Int J Mol Sci | Mitochondria Matter: Systemic Aspects of Nonalcoholic Fatty Liver Disease (NAFLD) and Diagnostic Assessment of Liver Function by Stable Isotope Dynamic Breath Tests. | 2021 | Details |
| A02640 | 34299189 | Int J Mol Sci | Current Options and Future Directions for NAFLD and NASH Treatment. | 2021 | Details |
| A02642 | 34298967 | Int J Mol Sci | Recent Progress in the Molecular Imaging of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02644 | 34298870 | Int J Mol Sci | Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance. | 2021 | Details |
| A02648 | 34298687 | Cancers (Basel) | Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to Chemoprevention. | 2021 | Details |
| A02652 | 34297733 | PLoS One | Long working hours are associated with a higher risk of non-alcoholic fatty liver disease: A large population-based Korean cohort study. | 2021 | Details |
| A02653 | 34297426 | Hepatology | Gastrodin Improves Nonalcoholic Fatty Liver Disease Through Activation of the Adenosine Monophosphate-Activated Protein Kinase Signaling Pathway. | 2021 | Details |
| A02655 | 34295993 | Clin Exp Hepatol | Comparative analysis of metabolic risk factors for progression of non-alcoholic fatty liver disease. | 2021 | Details |
| A02657 | 34295984 | Clin Exp Hepatol | Pemafibrate improves hepatic inflammation, function and fibrosis in patients with non-alcoholic fatty liver disease: a one-year observational study. | 2021 | Details |
| A02658 | 34294937 | Pathologica | Pathology of non-alcoholic fatty liver disease. | 2021 | Details |
| A02659 | 34294714 | Nat Commun | CD8+ tissue-resident memory T cells promote liver fibrosis resolution by inducing apoptosis of hepatic stellate cells. | 2021 | Details |
| A02660 | 34294656 | J Clin Gastroenterol | Identifying Patients at Risk for Fibrosis in a Primary Care NAFLD Cohort. | 2021 | Details |
| A02662 | 34294375 | J Pharmacol Sci | Ferulic acid attenuates non-alcoholic steatohepatitis by reducing oxidative stress and inflammation through inhibition of the ROCK/NF-κB signaling pathways. | 2021 | Details |
| A02665 | 34292604 | Hepatology | Salidroside Activates the AMP-Activated Protein Kinase Pathway to Suppress Nonalcoholic Steatohepatitis in Mice. | 2021 | Details |
| A02670 | 34290320 | Sci Rep | AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects. | 2021 | Details |
| A02673 | 34289507 | Semin Liver Dis | Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities. | 2021 | Details |
| A02675 | 34289397 | J Hepatol | Maternal obesity increases the risk and severity of NAFLD in offspring. | 2021 | Details |
| A02686 | 34284414 | Eur J Gastroenterol Hepatol | Heritability analysis of liver stiffness detected by ultrasound shear wave elastography: a twin study. | 2021 | Details |
| A02691 | 34280550 | Clin Gastroenterol Hepatol | Risk Difference of Liver-Related and Cardiovascular Events by Liver Fibrosis Status in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02692 | 34280515 | Adv Drug Deliv Rev | Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis. | 2021 | Details |
| A02693 | 34280397 | Eur J Pharmacol | Thymosin beta 4 alleviates non-alcoholic fatty liver by inhibiting ferroptosis via up-regulation of GPX4. | 2021 | Details |
| A02700 | 34278170 | Hepatol Commun | Colonoscopy and Risk of Colorectal Cancer in Patients With Nonalcoholic Fatty Liver Disease: A Retrospective Territory-Wide Cohort Study. | 2021 | Details |
| A02701 | 34278169 | Hepatol Commun | Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis. | 2021 | Details |
| A02707 | 34277457 | Front Oncol | Hepcidin Downregulation Correlates With Disease Aggressiveness And Immune Infiltration in Liver Cancers. | 2021 | Details |
| A02710 | 34276360 | Front Pharmacol | Network Pharmacological Analysis and Experimental Validation of the Mechanisms of Action of Si-Ni-San Against Liver Fibrosis. | 2021 | Details |
| A02712 | 34276197 | Ann Gastroenterol | Modest alcohol consumption and risk of advanced liver fibrosis in nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2021 | Details |
| A02713 | 34276185 | Ann Gastroenterol | Alcohol consumption in patients with nonalcoholic fatty liver disease: yes, or no? | 2021 | Details |
| A02714 | 34276153 | J Clin Exp Hepatol | Screening of Family Members of Nonalcoholic Fatty Liver Disease Patients can Detect Undiagnosed Nonalcoholic Fatty Liver Disease Among Them: Is There a Genetic Link? | 2020 | Details |
| A02716 | 34275749 | Hepatobiliary Pancreat Dis Int | Influence of weight management on the prognosis of steatohepatitis in chronic hepatitis B patients during antiviral treatment. | 2021 | Details |
| A02725 | 34272900 | Int J Eat Disord | Binge-eating disorder is associated with an unfavorable body mass composition in patients with non-alcoholic fatty liver disease. | 2021 | Details |
| A02726 | 34272738 | Hepatology | The E3 Ubiquitin Ligase Ring Finger Protein 5 Ameliorates NASH Through Ubiquitin-Mediated Degradation of 3-Hydroxy-3-Methylglutaryl CoA Reductase Degradation Protein 1. | 2021 | Details |
| A02732 | 34268860 | Liver Int | NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease. | 2021 | Details |
| A02734 | 34266657 | Clin Radiol | The feasibility of T2 mapping in the assessment of hepatic steatosis, inflammation, and fibrosis in patients with non-alcoholic fatty liver disease: a preliminary study. | 2021 | Details |
| A02741 | 34263075 | JGH Open | Validation of a two-step approach combining serum biomarkers and liver stiffness measurement to predict advanced fibrosis. | 2021 | Details |
| A02742 | 34263067 | JGH Open | Noninvasive measure of treatment response in non-alcoholic steatohepatitis: Insights from EMMINENCE and meta-analysis. | 2021 | Details |
| A02746 | 34262313 | Diabetes Metab Syndr Obes | Liver Stiffness Measurement by Using Transient Elastography in Bangladeshi Patients with Type 2 Diabetes Mellitus and Ultrasonography-Diagnosed Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A02752 | 34259747 | Rev Col Bras Cir | Is there a link between non-alcoholic fatty liver disease aspects and pancreatic cancer? Results of a case-matched study. | 2021 | Details |
| A02755 | 34257827 | Oxid Med Cell Longev | Changes in Key Mitochondrial Lipids Accompany Mitochondrial Dysfunction and Oxidative Stress in NAFLD. | 2021 | Details |
| A02760 | 34256994 | Hepatobiliary Pancreat Dis Int | LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver. | 2021 | Details |
| A02762 | 34254372 | Phytother Res | The effect of (Cornus mas L.) fruit extract on liver function among patients with nonalcoholic fatty liver: A double-blind randomized clinical trial. | 2021 | Details |
| A02764 | 34253010 | Diabetes Metab J | Renal Tubular Damage Marker, Urinary N-acetyl-β-D-Glucosaminidase, as a Predictive Marker of Hepatic Fibrosis in Type 2 Diabetes Mellitus. | 2021 | Details |
| A02765 | 34252441 | Eur J Pharmacol | Ferroptosis as a new therapeutic opportunity for nonviral liver disease. | 2021 | Details |
| A02767 | 34251031 | Aliment Pharmacol Ther | PRO-C3 and ADAPT algorithm accurately identify patients with advanced fibrosis due to alcohol-related liver disease. | 2021 | Details |
| A02768 | 34250613 | J Clin Periodontol | Elimination of Porphyromonas gingivalis inhibits liver fibrosis and inflammation in NASH. | 2021 | Details |
| A02770 | 34249975 | Front Med (Lausanne) | Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD. | 2021 | Details |
| A02773 | 34249410 | Am J Cancer Res | Targeting the eicosanoid pathway in hepatocellular carcinoma. | 2021 | Details |
| A02775 | 34248137 | Med Sci Monit | Editorial: International Consensus Recommendations to Replace the Terminology of Non-Alcoholic Fatty Liver Disease (NAFLD) with Metabolic-Associated Fatty Liver Disease (MAFLD). | 2021 | Details |
| A02776 | 34246549 | Hepatobiliary Pancreat Dis Int | The pathologic relevance of metabolic criteria in patients with biopsy-proven nonalcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease: A multicenter cross-sectional study in China. | 2021 | Details |
| A02779 | 34243681 | Pharm Biol | Esculin protects against methionine choline-deficient diet-induced non-alcoholic steatohepatitis by regulating the Sirt1/NF-κB p65 pathway. | 2021 | Details |
| A02780 | 34243194 | Semin Liver Dis | Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases. | 2021 | Details |
| A02781 | 34243193 | Semin Liver Dis | Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review. | 2021 | Details |
| A02782 | 34242868 | Comput Biol Med | Application of computer tongue image analysis technology in the diagnosis of NAFLD. | 2021 | Details |
| A02783 | 34242696 | J Hepatol | The multifaceted role of cathepsins in liver disease. | 2021 | Details |
| A02791 | 34239263 | World J Gastroenterol | Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements. | 2021 | Details |
| A02792 | 34239138 | Nat Med | Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial. | 2021 | Details |
| A02793 | 34238770 | Gut Liver | Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A02795 | 34237252 | Cell Metab | Liver-fibrosis-activated transcriptional networks govern hepatocyte reprogramming and intra-hepatic communication. | 2021 | Details |
| A02801 | 34234538 | Int J Gen Med | Correlation Between 25 Hydroxyvitamin D Levels and Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. | 2021 | Details |
| A02805 | 34234198 | Sci Rep | Utility of Fibroscan XL to assess the severity of non-alcoholic fatty liver disease in patients undergoing bariatric surgery. | 2021 | Details |
| A02806 | 34234100 | Cell Death Discov | Exosomes secreted by palmitic acid-treated hepatocytes promote LX-2 cell activation by transferring miRNA-107. | 2021 | Details |
| A02815 | 34231659 | Arq Gastroenterol | PERFORMACE OF TRIGLYCERIDE-GLUCOSE INDEX ON DIAGNOSIS AND STAGING OF NAFLD IN OBESE PATIENTS. | 2021 | Details |
| A02816 | 34231477 | Turk J Gastroenterol | Feasibility of Fibroscan in Assessment of Hepatic Steatosis and Fibrosis in Obese Patients: Report From a General Internal Medicine Clinic. | 2021 | Details |
| A02823 | 34229251 | Biomed Pharmacother | Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-κB signaling pathways. | 2021 | Details |
| A02828 | 34227068 | Eur Rev Med Pharmacol Sci | Liver changes in Wilson's disease: the full spectrum. A report of 127 biopsies from 43 patients. | 2021 | Details |
| A02830 | 34226630 | Sci Rep | The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases. | 2021 | Details |
| A02833 | 34225440 | Zhonghua Gan Zang Bing Za Zhi | [Research progress of omics biomarkers for nonalcoholic fatty liver disease]. | 2021 | Details |
| A02834 | 34225438 | Zhonghua Gan Zang Bing Za Zhi | [Mechanism of T lymphocyte subsets in the malignant transformation of non-alcoholic fatty liver disease]. | 2021 | Details |
| A02836 | 34224858 | Pharmacol Res | Mastiha has efficacy in immune-mediated inflammatory diseases through a microRNA-155 Th17 dependent action. | 2021 | Details |
| A02840 | 34222711 | Curr Opin Endocr Metab Res | Pediatric nonalcoholic fatty liver disease and the microbiome: Mechanisms contributing to pathogenesis and progression. | 2021 | Details |
| A02846 | 34221262 | Gastroenterol Hepatol Bed Bench | Is melatonin associated with pro-inflammatory cytokine activity and liver fibrosis in non-alcoholic fatty liver disease (NAFLD) patients? | 2021 | Details |